文献速递创伤与烧伤复苏、休克与脓毒症

寻找出血边缘:2002至2020年战斗伤员中按输血制品单位数分层的24小时死亡率

Finding the bleeding edge: 24-hour mortality by unit of blood product transfused in combat casualties from 2002-2020.
PubMed 文献 · J Trauma Acute Care Surg · 2023-07-03
一句话结论战斗伤员中,接受超过100单位血制品者79.3%存活至24小时,结果不支持血制品输注的徒劳阈值。

该回顾性分析基于国防部创伤登记库并补充武装部队法医数据,纳入2002至2020年在美国战斗环境中军事医疗设施接受至少1单位血制品的战斗伤员11746例。主要干预为从受伤至首个部署医疗设施入院后24小时内输注的任何血制品总单位数,主要结局为受伤后24小时出院状态(存活或死亡)。中位年龄24岁,男性94.2%,穿透伤84.7%,中位损伤严重度评分17,783例(6.7%)在24小时内死亡,中位输血8单位。在输血超过100单位的58例中,24小时死亡率为20.7%(即79.3%存活),结果不支持血制品输注的徒劳阈值。

要点

  • 在输血超过100单位的58例战斗伤员中,20.7%在24小时内死亡,79.3%存活至24小时。
  • 接受血制品最多的10例(164至290单位)中,7例存活至24小时;存活者中最大输血总量为276单位。
  • 总体11746例中783例(6.7%)在24小时内死亡,中位输血8单位,中位损伤严重度评分17。
  • 输注血制品以红细胞为主(50.2%),其次为血浆(41.1%)、血小板(5.5%)和全血(3.2%)。
  • 研究结论认为这些结果不支持血制品输注存在徒劳阈值,需进一步分析死亡预测因素以应对血制品和资源受限情况。

适用人群与场景

  • 2002至2020年在美国战斗环境中军事医疗设施接受至少1单位血制品的战斗伤员。
  • 中位年龄24岁,男性94.2%,穿透伤84.7%,中位损伤严重度评分17。

研究设计与关键结果

  • 研究类型为回顾性分析,数据来自国防部创伤登记库并补充武装部队法医数据,纳入11746例战斗伤员。
  • 主要干预为从受伤至首个部署医疗设施入院后24小时内输注的任何血制品总单位数;主要结局为受伤后24小时出院状态(存活或死亡)。
  • 783例(6.7%)在24小时内死亡;中位输血8单位。
  • 血制品构成:红细胞50.2%、血浆41.1%、血小板5.5%、全血3.2%。
  • 接受血制品最多的10例(164至290单位)中7例存活至24小时;存活者中最大输血总量为276单位。
  • 输血超过100单位的58例中,20.7%在24小时内死亡(即79.3%存活至24小时)。

证据类型、等级与局限

  • 证据类型:回顾性分析(预后与流行病学研究),证据等级Level IV。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为这些结果不支持血制品输注的徒劳阈值。
  • 作者指出需进一步分析死亡预测因素,以应对血制品和资源受限的情况。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Transfusion studies in civilian trauma patients have tried to identify a general futility threshold. We hypothesized that in combat settings there is no general threshold where blood product transfusion becomes unbeneficial to survival in hemorrhaging patients. We sought to assess the relationship between the number of units of blood products transfused and 24-hour mortality in combat casualties.

METHODS: A retrospective analysis of the Department of Defense Trauma Registry supplemented with data from the Armed Forces Medical Examiner. Combat casualties who received at least one unit of blood product at US military medical treatment facilities (MTFs) in combat settings (2002-2020) were included. The main intervention was the total units of any blood product transfused, which was measured from the point of injury until 24 hours after admission from the first deployed MTF. The primary outcome was discharge status (alive, dead) at 24 hours from time of injury.

RESULTS: Of 11,746 patients included, the median age was 24 years, and most patients were male (94.2%) with penetrating injury (84.7%). The median injury severity score was 17 and 783 (6.7%) patients died by 24 hours. Median units of blood products transfused was 8. Most blood products transfused were red blood cells (50.2%), followed by plasma (41.1%), platelets (5.5%), and whole blood (3.2%). Among the 10 patients who received the most units of blood product (164 units to 290 units), 7 survived to 24 hours. The maximum amount of total blood products transfused to a patient who survived was 276 units. Of the 58 patients who received over 100 units of blood product, 20.7% died by 24 hours.

CONCLUSION: While civilian trauma studies suggest the possibility of futility with ultra-massive transfusion, we report that the majority (79.3%) of combat casualties who received transfusions greater than 100 units survived to 24 hours. These results do not support a threshold for futility of blood product transfusion. Further analysis as to predictors for mortality will help in situations of blood product and resource constraints.

LEVEL OF EVIDENCE: Prognostic and Epidemiological; Level IV.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Gurney JM, Staudt AM, Holcomb JB, et al. Finding the bleeding edge: 24-hour mortality by unit of blood product transfused in combat casualties from 2002-2020. J Trauma Acute Care Surg. 2023. PMID: 37399037. doi:10.1097/TA.0000000000004028

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。